AMC, BioSpecifics rise; American Equity, Host Hotels fall

→ The system that called 2023’s top 7 stocks is at it again… (From WealthPress) (Ad)

NEW YORK (AP) — Stocks that moved heavily or traded substantially Monday:

ConocoPhillips, down $1.07 to $32.70

The energy company is buying rival Concho Resources in an all-stock deal valued at $9.7 billion.

American Equity Investment Life, down $4.81 to $27.49

The life insurance company is selling a 19.9% stake to Brookfield Asset Management and rejecting a takeover bid from Athene and MassMutual.

Get Enveric Biosciences alerts:

Front Yard Residential, up $3.48 to $13.44

The rental property owner is being bought by Pretium and Ares Management.

Host Hotels & Resorts, down 28 cents to $10.67

The hotel owner is transferring its stock listing to the Nasdaq from the New York Stock Exchange.

South Mountain Merger, up $1.61 to $11.96

The acquisition company is buying payment processing software company Billtrust in a $1.3 billion deal.

BioSpecifics Technologies, up $27.67 to $88.69

Endo International is buying the biotechnology company in a deal valued at $540 million.

Cree, up $2.64 to $73.93

The lighting products maker is selling its LED products business to Smart Global Holdings.

AMC Entertainment, up 50 cents to $3.54

The movie theater operator said it plans to reopen many locations throughout New York by the end of the week.

Ad WealthPress

The system that called 2023’s top 7 stocks is at it again…

Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.

Just follow this link here!

→ Did you know you can now trade Bitcoin in your regular brokerage account? (From DTI) (Ad)

Should you invest $1,000 in Enveric Biosciences right now?

Before you consider Enveric Biosciences, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enveric Biosciences wasn't on the list.

While Enveric Biosciences currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here